Some people with cancer of unknown primary (CUP) may be offered targeted therapy. This is a type of drug therapy that attacks specific features of cancer cells to stop the cancer growing and spreading. Many targeted therapy drugs are given by mouth as tablets, but some are given by injection.
Learn more about:
- Is targeted therapy suitable for you?
- Side effects of targeted therapy
- Immunotherapy for CUP
- Video: What are targeted therapy and immunotherapy?
- Podcast: Immunotherapy & Targeted Therapy
Is targeted therapy suitable for you?
Only a small number of CUP tumours will be suitable for targeted therapy. Your doctors will need to test the cancer to see if the cells have a particular cell change that is helping the cancer grow.
Side effects of targeted therapy
Targeted therapy drugs minimise harm to healthy cells, but they can still have side effects. These side effects vary greatly depending on the drug used and how your body responds.
Common side effects of targeted therapy include:
- skin rashes
- fever
- tiredness
- joint aches
- nausea
- diarrhoea
- bleeding and bruising
- high blood pressure.
For more on this, see our general section on Targeted therapy.
Immunotherapy for CUP
Immunotherapy uses the body’s own immune system to fight cancer. Sometimes the results of specialised tests on a CUP tumour may suggest that immunotherapy could help to treat the cancer.
More evidence is needed to tell whether immunotherapy works for CUP, so it isn’t funded on the Pharmaceutical Benefits Scheme (PBS) yet. However, immunotherapy may be accessed if tests strongly suggest you have one of the other cancer types that are funded on the PBS. Immunotherapy may also sometimes be accessed through clinical trials.
For more on this, see our general section on Immunotherapy.
It is important to tell your treatment team about any side effects you have from drug therapies. Side effects can be better managed when reported early. You may be given medicine to prevent or reduce side effects. Sometimes, your doctor may delay treatment or reduce the dose to lessen side effects.
You may be able to get other drugs to treat CUP through clinical trials. Ask your doctor about recent developments and whether a clinical trial may be an option for you.
→ READ MORE: Radiation therapy for CUP
Video: What are targeted therapy and immunotherapy?
If you have cancer, drug therapy may play a big role in your treatment plan. Watch this short video to learn more about drug therapies, including targeted and immunotherapy.
Podcast: Immunotherapy & Targeted Therapy
More resources
Prof Chris Karapetis, Network Clinical Director (Cancer Services), Southern Adelaide Local Health Network, Head, Department of Medical Oncology, and Director, Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders University, SA (Clinical review); Dr Amey Aurangabadkar, Radiologist, Illawarra Radiology Group, NSW; Clare Brophy, Consumer; Prof Katherine Clark, Clinical Director of Palliative Care, NSLHD Supportive and Palliative Care Network, Northern Sydney Cancer Centre, Royal North Shore Hospital, NSW; Prof Wendy Cooper, Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, NSW; A/Prof Richard Gallagher, Head and Neck Surgeon, Director of Cancer Services and Head and Neck Cancer Services, St Vincent’s Health Network, NSW; Dr Chloe Georgiou, Oncology Research Fellow, Australian Rare Cancer Portal, and Oncology Trials Fellow, Bendigo Health Cancer Centre, VIC; Dr Susan Harden, Radiation Oncologist, Peter MacCallum Cancer Centre, VIC; Justin Hargreaves, Medical Oncology Nurse Practitioner, Bendigo Health Cancer Centre, VIC; Dr Laura Kirsten, Principal Clinical Psychologist, Nepean Cancer Care Centre, NSW; Prof Linda Mileshkin, Medical Oncologist, Peter MacCallum Cancer Centre, VIC; Caitriona Nienaber, 13 11 20 Consultant, Cancer Council WA.
View the Cancer Council NSW editorial policy.
